Prosecution Insights
Last updated: October 04, 2026

L'Oeal

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

L'Oeal currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to a distinct examiner and is situated within 1 distinct art unit. The concentration of the pending workload suggests a narrow focus for the company's current biotechnology-related prosecution efforts, with all activity funneling through a single point of review.

The busiest examiner identified in the data is GOTFREDSON, GAREN, who is responsible for the pending office action. Since the portfolio contains only an individual examiner and art unit, the prosecution experience is currently uniform across the company's pending applications. Practitioners should monitor the specific requirements of GOTFREDSON, GAREN to navigate the active office action successfully.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GOTFREDSON, GAREN 1 40.0% +28.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18258091 USE OF A SHORT CHAIN FATTY ACID AS ANTIDANDRUFF AGENT GOTFREDSON, GAREN —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18258091 USE OF A SHORT CHAIN FATTY ACID AS ANTIDANDRUFF AGENT GOTFREDSON, GAREN —

Top Art Units

Art UnitApps
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18258091 USE OF A SHORT CHAIN FATTY ACID AS ANTIDANDRUFF AGENT GOTFREDSON, GAREN 1619 §102§103Other Final Rejection — Pending Jun 30, 2023

Managing L'Oeal's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month